Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.
Announcements
5,263
Total raised
£158B
disclosed amounts
The London-based company raised capital from Accel, Air Street Capital, and Elder Gull to grow its engineering team and scale deployments.
"Too many critical drug development decisions still happen without a complete view of the evidence. Perceptic connects data, context, and decision-making so every insight compounds instead of dying at the next handoff."
The London deeptech startup secured backing from Ascension Ventures to scale its voice biometrics technology.
"Voice is the last unencrypted frontier in enterprise security, and generative AI just made the stakes existential. Voxmind’s physics-based approach, on-device deployment, and existing OEM footprint give them a structural advantage that’s very difficult to replicate. Excited to lead this round and back the team as they scale."
The London-based startup secured the capital from a group of more than 20 angel investors.
"I left school in Leeds at the age of 18 and landed a job as an apprentice at KPMG in London,"
The funding round was led by Mercia Ventures with participation from Techstart Ventures and angel investors.
"Corporate gifting is a trillion-dollar industry that spent decades normalising mediocrity because no one built a competitively viable alternative. We started Go Swag with less than £200 and the belief that every gift a company puts its name on either strengthens the brand or quietly undermines it. This funding allows us to take this conviction global, beginning with a major US market expansion. The catalogue is dead and we’re replacing it with smart AI-assisted curation and a better gifting process to match."
THENA Capital led the seed round to help advance Zonova toward major OEM partnerships and international deployment.
"This funding marks a defining moment for Zonova. We founded the company with the belief that infection prevention in medical devices needed a fundamentally new approach, one that moves beyond coatings, antibiotics, and short term fixes. Our technology has the potential to redefine how medical devices are designed globally by embedding antimicrobial protection directly into the material itself. THENA Capital immediately understood both the scale of the clinical problem and the magnitude of the commercial opportunity. The THENA team brings an exceptional combination of scientific depth, strategic insight, and operational ambition that is incredibly rare in venture. We are thrilled to have them leading this round and joining us as we scale toward major OEM partnerships and international deployment."
